Re: Statistical Considerations
|
4
|
Resverlogix Corp.
|
Mar 07, 2018 07:24PM
|
Of interest during this pending financing period
|
2
|
Resverlogix Corp.
|
Mar 07, 2018 04:31PM
|
Re: Chinese Takeovers
|
|
Zenith Epigenetics
|
Mar 07, 2018 03:56PM
|
Re: Statistical Considerations
|
1
|
Resverlogix Corp.
|
Mar 07, 2018 01:42PM
|
Re: Statistical Considerations
|
|
Resverlogix Corp.
|
Mar 07, 2018 10:57AM
|
Re: Chinese Takeovers
|
1
|
Zenith Epigenetics
|
Mar 07, 2018 10:49AM
|
Re: Statistical Considerations
|
1
|
Resverlogix Corp.
|
Mar 06, 2018 03:04PM
|
Re: AACR 2018
|
2
|
Zenith Epigenetics
|
Mar 06, 2018 01:24PM
|
Re: AACR 2018
|
2
|
Zenith Epigenetics
|
Mar 06, 2018 01:15PM
|
Re: Statistical Considerations
|
4
|
Resverlogix Corp.
|
Mar 06, 2018 12:30PM
|
Re: Blood test coming for Earlier Detection of Alzheimer's
|
2
|
Resverlogix Corp.
|
Mar 06, 2018 10:58AM
|
Re: ... yah but when...?
|
3
|
Resverlogix Corp.
|
Mar 06, 2018 10:34AM
|
Re: AACR 2018
|
1
|
Zenith Epigenetics
|
Mar 05, 2018 03:13PM
|
Statistical Considerations
|
3
|
Resverlogix Corp.
|
Mar 05, 2018 01:55PM
|
Re: AACR 2018
|
2
|
Zenith Epigenetics
|
Mar 01, 2018 05:17PM
|
Re: AACR 2018
|
2
|
Zenith Epigenetics
|
Feb 28, 2018 05:41PM
|
Re: News !!!
|
4
|
Resverlogix Corp.
|
Feb 27, 2018 08:44PM
|
Re: Wonder if they're already in NYC getting ready for the conference?
|
|
Resverlogix Corp.
|
Feb 16, 2018 01:43PM
|
Re: Story time with tada
|
3
|
Resverlogix Corp.
|
Feb 16, 2018 01:37PM
|
Re: Update
|
1
|
Resverlogix Corp.
|
Feb 16, 2018 12:30PM
|